ABACUS MEDICINE A/S — Credit Rating and Financial Key Figures
CVR number: 28111576
Kalvebod Brygge 35, 1560 København V
info@abacusmedicine.com
tel: 70220212
www.abacusmedicine.com
Income statement (mEUR)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 663.50 | 940.74 | 1 023.98 | 1 210.35 | 1 486.96 |
| Costs of manufacturing | - 595.94 | - 859.21 | - 918.44 | -1 066.23 | -1 315.94 |
| External services | -20.37 | -22.98 | -26.49 | -29.97 | -40.54 |
| Gross profit | 47.19 | 58.56 | 79.05 | 114.16 | 130.48 |
| Employee benefit expenses | -34.23 | -42.00 | -52.89 | -66.65 | -79.94 |
| Other operating expenses | -0.48 | ||||
| Total depreciation | -7.14 | -10.16 | -11.44 | -11.94 | -13.05 |
| EBIT | 5.35 | 6.40 | 14.72 | 35.57 | 37.49 |
| Other financial income | 0.17 | 0.08 | 0.07 | 1.66 | 1.60 |
| Other financial expenses | -4.10 | -4.41 | -6.17 | -14.67 | -17.59 |
| Net income from associates (fin.) | -0.08 | -0.02 | -0.12 | 3.13 | 0.00 |
| Pre-tax profit | 1.34 | 2.06 | 8.51 | 25.69 | 21.51 |
| Income taxes | -0.90 | -1.65 | -2.69 | -5.64 | -3.89 |
| Net earnings | 0.43 | 0.41 | 5.82 | 20.04 | 17.62 |
Assets (mEUR)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible rights | 30.13 | 32.44 | 33.15 | 36.67 | 38.11 |
| Intangible assets total | 30.13 | 32.44 | 33.15 | 36.67 | 38.11 |
| Machinery and equipment | 11.34 | 10.97 | 10.43 | 10.55 | 18.97 |
| Other tangible assets | 5.35 | 9.81 | 9.48 | 7.66 | 6.67 |
| Tangible assets total | 16.70 | 20.78 | 19.91 | 18.20 | 25.64 |
| Participating interests | 0.07 | 0.12 | 0.08 | 0.08 | 0.08 |
| Investments total | 0.07 | 0.12 | 0.08 | 0.08 | 0.08 |
| Non-current other receivables | 0.47 | 0.40 | 0.53 | 0.23 | 0.23 |
| Deferred tax assets | 3.66 | 4.18 | 4.57 | 4.89 | 6.63 |
| Long term receivables total | 4.12 | 4.58 | 5.10 | 5.13 | 6.86 |
| Inventories total | 108.54 | 113.47 | 116.79 | 199.88 | 229.48 |
| Current trade debtors | 59.75 | 40.31 | 47.97 | 55.71 | 47.14 |
| Short term receivables total | 59.75 | 40.31 | 47.97 | 55.71 | 47.14 |
| Cash and bank deposits | 0.22 | 3.89 | 9.97 | 3.27 | 9.99 |
| Cash and cash equivalents | 0.22 | 3.89 | 9.97 | 3.27 | 9.99 |
| Balance sheet total (assets) | 219.53 | 215.58 | 232.98 | 318.94 | 357.30 |
Equity and liabilities (mEUR)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 0.51 | 0.52 | 0.52 | 0.52 | 0.52 |
| Other reserves | -0.20 | -0.41 | -0.23 | -0.68 | -3.74 |
| Retained earnings | 52.29 | 54.12 | 54.89 | 60.99 | 81.50 |
| Profit of the financial year | 0.43 | 0.41 | 5.82 | 20.04 | 17.62 |
| Shareholders equity total | 53.02 | 54.65 | 60.99 | 80.87 | 95.89 |
| Non-current leasing loans | 3.61 | 7.79 | 7.38 | 5.02 | 3.53 |
| Non-current other liabilities | 1.25 | 4.62 | 2.24 | 2.07 | 1.39 |
| Non-current deferred tax liabilities | 3.31 | 4.25 | 4.33 | 1.78 | 1.49 |
| Non-current liabilities total | 8.17 | 16.66 | 13.96 | 8.87 | 6.41 |
| Current leasing loans | 1.78 | 2.35 | 2.83 | 3.42 | 3.82 |
| Current trade creditors | 62.70 | 66.92 | 84.33 | 131.63 | 168.14 |
| Short-term deferred tax liabilities | 0.78 | 0.72 | 2.81 | 6.97 | 4.25 |
| Other non-interest bearing current liabilities | 87.07 | 70.15 | 63.80 | 81.80 | 72.46 |
| Current provisions | 6.01 | 4.13 | 4.26 | 5.39 | 6.33 |
| Current liabilities total | 158.34 | 144.27 | 158.03 | 229.20 | 255.00 |
| Balance sheet total (liabilities) | 219.53 | 215.58 | 232.98 | 318.94 | 357.30 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.